This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
CHMP Recommends Lilly and Boehringer Ingelheim’s New Insulin Glargine Product for Approval in the European Union
Studies Show Investigational New Insulin Glargine Product from Lilly and Boehringer Ingelheim Similar in Safety and Efficacy to Lantus®- For Non-U.S. and Non-UK Media
Diabetes: Boehringer Ingelheim and Eli Lilly and Company Alliance to have 43 Presentations Featured at the American Diabetes Association’s 74th Scientific Sessions®- For Non-US and Non-UK Media
Type 2 Diabetes: European Commission approves Jardiance® (empagliflozin)
Type 2 Diabetes: CHMP recommends empagliflozin* for approval
Diabetes Related News Room